These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
231 related articles for article (PubMed ID: 18058493)
1. The enigma of rosacea. Marks R J Dermatolog Treat; 2007; 18(6):326-8. PubMed ID: 18058493 [TBL] [Abstract][Full Text] [Related]
2. Pathophysiology of rosacea: redness, telangiectasia, and rosacea. Cribier B Ann Dermatol Venereol; 2011 Nov; 138 Suppl 3():S184-91. PubMed ID: 22183097 [TBL] [Abstract][Full Text] [Related]
3. [Physiopathology of rosacea. Redness, telangiectasia, and rosacea]. Cribier B Ann Dermatol Venereol; 2011 Sep; 138 Suppl 2():S129-37. PubMed ID: 21907872 [TBL] [Abstract][Full Text] [Related]
4. Rosacea: part I. Introduction, categorization, histology, pathogenesis, and risk factors. Two AM; Wu W; Gallo RL; Hata TR J Am Acad Dermatol; 2015 May; 72(5):749-58; quiz 759-60. PubMed ID: 25890455 [TBL] [Abstract][Full Text] [Related]
5. A study of the pathogenesis of rosacea: how angiogenesis and mast cells may participate in a complex multifactorial process. Aroni K; Tsagroni E; Kavantzas N; Patsouris E; Ioannidis E Arch Dermatol Res; 2008 Mar; 300(3):125-31. PubMed ID: 18071725 [TBL] [Abstract][Full Text] [Related]
7. Rosacea: I. Etiology, pathogenesis, and subtype classification. Crawford GH; Pelle MT; James WD J Am Acad Dermatol; 2004 Sep; 51(3):327-41; quiz 342-4. PubMed ID: 15337973 [TBL] [Abstract][Full Text] [Related]
8. The pathophysiology of rosacea. Mc Aleer MA; Lacey N; Powell FC G Ital Dermatol Venereol; 2009 Dec; 144(6):663-71. PubMed ID: 19907405 [TBL] [Abstract][Full Text] [Related]
9. [A histological and immunohistological study of vascular and inflammatory changes in rosacea]. Perrigouard C; Peltre B; Cribier B Ann Dermatol Venereol; 2013 Jan; 140(1):21-9. PubMed ID: 23328356 [TBL] [Abstract][Full Text] [Related]
10. A new treatment regimen for rosacea: onabotulinumtoxinA. Dayan SH; Pritzker RN; Arkins JP J Drugs Dermatol; 2012 Dec; 11(12):e76-9. PubMed ID: 23377526 [TBL] [Abstract][Full Text] [Related]
12. Videocapillaroscopic alterations in erythematotelangiectatic rosacea. Rosina P; Zamperetti MR; Giovannini A; Chieregato C; Girolomoni G J Am Acad Dermatol; 2006 Jan; 54(1):100-4. PubMed ID: 16384763 [TBL] [Abstract][Full Text] [Related]
13. Remission of rosacea induced by reduction of gut transit time. Kendall SN Clin Exp Dermatol; 2004 May; 29(3):297-9. PubMed ID: 15115515 [TBL] [Abstract][Full Text] [Related]
14. [Rosacea in the year 2001]. Thissen MR; Neumann HA Ned Tijdschr Geneeskd; 2001 Sep; 145(37):1778-82. PubMed ID: 11582639 [TBL] [Abstract][Full Text] [Related]
15. Ultraviolet light and rosacea. Murphy G Cutis; 2004 Sep; 74(3 Suppl):13-6, 32-4. PubMed ID: 15499753 [TBL] [Abstract][Full Text] [Related]
16. The association of photo-induced collagen degeneration and the development of telangiectasias in rosacea. Thompson KG; Rainer BM; Leung S; Qi J; Kang S; Chien AL J Anat; 2021 Jun; 238(6):1355-1358. PubMed ID: 33432575 [TBL] [Abstract][Full Text] [Related]
17. Rosacea: current thoughts on origin. Bamford JT Semin Cutan Med Surg; 2001 Sep; 20(3):199-206. PubMed ID: 11594675 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of rosacea in an Estonian working population using a standard classification. Abram K; Silm H; Oona M Acta Derm Venereol; 2010 May; 90(3):269-73. PubMed ID: 20526544 [TBL] [Abstract][Full Text] [Related]